Cbd Bioavailability News Today

(Watkins, CO – April 30, 2024) – Kazmira, a name synonymous with excellence and innovation in the cannabis industry, is proud to announce its strategic pivot towards a groundbreaking endeavor – Kazmira Therapeutics. This shift comes in the wake of a proposal from the DEA moving to reschedule cannabis, marking

Join us on December 6th for a pivotal moment on Capitol Hill, where one of Kazmira’s dynamic co-founders and co-CEO, Mr. Pulak Sharma, will be in attendance.As a hemp industry pioneer and member of the ONE HEMP coalition, we’ll be participating in a high-profile briefing, with both the House and

Colorado has been the leader in cannabis since 2012, when we, along with Washington, became the first two states in the nation to legalize and regulate cannabis for recreational purposes through the approval of Amendment 64. Since then, almost half of the US states have also followed suit, making Colorado

In business, the process of making facts or information known to the public is called disclosure.  ‘Valuable Disclosures’ are the most important admissions a company can share with a consumer, and often become the most important part of their decision-making process. When it comes to consumer products, clarity around the

A New Regulatory Pathway is AheadSince the 2018 Farm Bill, the FDA has been looking at the food ingredients and dietary supplement pathways, within the Federal Food, Drug, & Cosmetic Act (FDCA), to regulate CBD products. Over four years later, an important update from the FDA finally came on January

Purpose & ImportanceFollowing the passing of Colorado Bill SB22-205, twenty hemp and marijuana industry stakeholders were appointed to a Task Force to study intoxicating hemp products and make legislative recommendations. Out of the 180 applications received, our co-CEO, Dr. Priyanka Sharma, was invited as one of the stakeholders to the

(Watkins, CO  – January 14, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and

(Watkins, CO  – January 14, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and

Kazmira Joins ValidCare Clinical Safety Study for CBD ProductsKazmira and other CBD brands will assess CBD safety profiles with end-consumersKazmira, a technology based cannabinoid ingredient manufacturer, is partnering with ValidCare to participate in a large clinical safety study for CBD products. Kazmira joins the second cohort of brands participating in

  Co-CEO & Co-Founder Dr. Priyanka Sharma spoke with Hemp Industry Daily on a roundtable with leaders and entrepreneurs throughout the industry. They reflect on how COVID-19 has affected hemp and CBD companies, discussing the challenges, the changes, and the future of the industry.